Related Experiment Video
Updated: Aug 14, 2026
10:18
In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium
Published on: May 6, 2018
Capoten-induced juxtaglomerular hyperplasia in rabbits
Research Communications in Chemical Pathology and Pharmacology
|April 1, 1982
Summary
Captopril, a converting enzyme inhibitor, significantly lowered blood pressure and aldosterone in rabbits over six months. It also increased plasma renin activity (PRA) and caused juxtaglomerular apparatus hyperplasia in kidneys.
Area of Science:
- Pharmacology
- Nephrology
- Cardiovascular Physiology
Background:
- Converting enzyme (CE) inhibitors are crucial in managing hypertension.
- Understanding long-term effects of CE inhibitors on the renin-angiotensin-aldosterone system (RAAS) and kidney is vital.
Purpose of the Study:
- To investigate the chronic effects of captopril on blood pressure, RAAS components, and kidney morphology in rabbits.
Main Methods:
- Rabbits were administered captopril (approx. 5.0 mg/kg/day) for six months.
- Measurements included mean arterial pressure, CE activity, plasma aldosterone, and plasma renin activity (PRA).
- Kidney morphology was assessed via microscopic examination.
Main Results:
- Captopril significantly reduced mean arterial pressure, CE activity, and aldosterone levels.
- Plasma renin activity (PRA) and renal renin activity were significantly increased.
- Marked hyperplasia of the juxtaglomerular apparatus was observed in all treated rabbits.
Conclusions:
- Chronic captopril administration effectively lowers blood pressure and aldosterone, consistent with CE inhibition.
- The observed increase in PRA and renal renin activity suggests a compensatory feedback mechanism.
- Juxtaglomerular apparatus hyperplasia indicates a significant adaptive response of the kidney to long-term CE inhibition.
